Lab Automation Industry Overview

The global lab automation market size was estimated at USD 6.87 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 6.64% from 2023 to 2030.

Laboratory automation utilizes a special kind of technology to streamline or substitute the manual manipulation of methods and equipment. Based on the laboratory workflow, the level and degree of automation are decided. The higher adoption of automated instruments is most often observed at academic and research institutes to bolster productivity and decrease the time spent on different time-consuming tasks.

In addition, the rising use of automated instruments for drug discovery and development purposes is further anticipated to propel the market growth during the forecast period. For instance, in June 2022, Insilico Medicine announced its plans to launch an automated AI-driven robotics laboratory for drug discovery.

Gather more insights about the market drivers, restrains and growth of the Lab Automation Market

The increasing number of benefits offered by process automation is one of the critical factors driving the growth of the market. For clinical laboratories, a paradigm shift from manual operation to laboratory automation has several advantages. Some major advantages of lab automation include enhanced productivity, safe working conditions, reliable results, and a great saving of time, effort, and overall cost of the product.

Moreover, lab automation facilitates the efficiency of laboratory equipment for processes such as sample handling, verifications, and labeling tubes, and helps lower the physical strain due to manual processes. Thus, numerous benefits offered by automated systems are projected to facilitate small and medium-scale laboratories to use automated systems for enhanced productivity.

Increase in demand for miniaturization of the process is another factor driving the global market. One of the main reasons for the adoption of automated technologies in clinical laboratories is to accelerate the miniaturization of research processes to derive solutions for various complex lab automation processes for applications such as microbiology, biotechnology, and clinical chemistry. Moreover, miniaturization makes it simpler to expand, monitor, and cultivate cells, which speeds up turnaround times, particularly in point-of-care settings.

Moreover, the market growth is expected to be driven by the increasing range of applications for lab automation. Various laboratory processes that were formerly done manually have been revolutionized by lab automation. Automated chemistry, synthetic biology, cell line development, genomics, cellular assays, drug discovery, and other applications are among them. Therefore, the adoption of lab automation systems is anticipated to be fueled by the expanding clinical applications of automated instruments in laboratories.

Browse through Grand View Research's Biotechnology Industry Research Reports.

• The global biotechnology market was valued at USD 1.55 trillion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 13.96% from 2024 to 2030.
• The global synthetic biology market size was valued at USD 13.09 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 18.97% from 2023 to 2030.

Lab Automation Market Segmentation

Grand View Research has segmented the global lab automation market based on process, automation type, end-use, and region:

Lab Automation Process Outlook (Revenue, USD Million, 2018 - 2030)

• Continuous Flow
  • By Workflow
    • Sequential Processing
    • Parallel Processing
  • By Components
    • Consumables
    • Equipment
  • Discrete Processing
    • By Method
      • Centrifugal Discrete Processing
      • Random Access Discrete Processing
    • By Components
      • Consumables
      • Equipment
    • By Workflow
      • Dependent Analysis
      • Independent Analysis

Lab Automation Type Outlook (Revenue, USD Million, 2018 - 2030)

• Total Automation Systems
  • By Steps
    • Pre-analysis
      • Centrifugation
      • Sample Preparation
      • Sample Sorting
    • Transport Mechanisms
    • Liquid Handling
    • Sample Storage
    • Sample Analysis
  • Modular Automation Systems
    • By Steps
      • Specimen Acquisition & Identification & Labelling
      • Transport Mechanisms
      • Sample Preparation
      • Sample Loading & Aspiration
      • Reagent Handling & Storage
      • Sample Analysis & Measurements

Lab Automation End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Clinical Chemistry Analysis
• Photometry & Fluorometry
• Immunoassay Analysis
• Electrolyte Analysis
• Other end-uses

Lab Automation Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Sweden
  • Denmark
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Key Companies profiled:

• QIAGEN
• PerkinElmer Inc.
• Thermo Fisher Scientific, Inc.
• Siemens Healthcare GmbH
• Danaher
• Agilent Technologies, Inc.
• Eppendorf SE
• Hudson Robotics
• Aurora Biomed Inc.
• BMG LABTECH GmbH
• Tecan Trading AG
• Hamilton Company
• Hoffmann-La Roche Ltd

Key Lab Automation Company Insights

The key players in the market are undertaking various strategic initiatives to maintain their market presence. In addition, these initiatives help players bolster their business avenues. For instance, in January 2023 Becton, Dickinson and Company (BD) launched its third-generation lab automation system for microbiology labs. The newly launched BD Kiestra is an ideal solution for automating lab specimen processing. 

Order a free sample PDF of the Lab Automation Market Intelligence Study, published by Grand View Research.